Abstract
Pedobacter heparinus heparin lyase II (PhHepII) is composed of N-terminal, central, and C-terminal domains. A long surface loop, designated loop-A, is in the N-terminal domain and is composed of amino acids 84-89. In this study, we deleted two, three, or four residues in loop-A to create Δ86-87, Δ85-87, and Δ84-87 PhHepII deletion mutants. We hypothesized that the deletions would increase PhHepII thermostability. After heating purified PhHepII enzymes at 45 °C for 5 min, 6.1 % of the enzyme activity remained in wild-type PhHepII, whereas 10.6 % of the enzyme activity remained in Δ86-87 PhHepII. The results indicated that the deletion caused a significant decrease in the activity, although Δ86-87 PhHepII is slightly more thermostable than wild-type PhHepII. In addtion, Δ85-87 and Δ84-87 PhHepII had weak or no enzyme activity, even when unheated. Circular dichroism spectra showed that Δ85-87 PhHepII was properly folded. These results suggest that the flexibility of loop-A is important for PhHepII enzyme activity.
Keywords: heparin lyase, PL21, Pedobacter heparinus, thermostability, surface loop, mutagenesis
Abbreviations
GuHCl, guanidine hydrochloride; Ni-NTA, nickel-nitrilotriacetic acid; PhHepII, Pedobacter heparinus heparin lyase II; WT, wild-type.
INTRODUCTION
The polysaccharides heparin and heparan sulfate are classified as glycosaminoglycans and are composed of heterogeneously sulfated repeating disaccharides of iduronic acid (or glucuronic acid) and glucosamine.1) The degree of sulfation is higher for heparin than for heparan sulfate. Heparin lyases degrade heparin and heparan sulfate via a β-elimination mechanism.2) 3) Three types of heparin lyases, HepI, HepII, and HepIII, have been identified. HepI primarily degrades heparin (EC 4.2.2.7), and HepIII primarily degrades heparan sulfate (EC 4.2.2.8), but HepII degrades both heparin and heparan sulfate.4) 5) According to the carbohydrate-active enzymes database (CAZy),6) HepI, HepII, and HepIII belong to polysaccharide lyase families PL13, PL21, and PL12, respectively.
Pedobacter heparinus (formerly known as Flavobacterium heparinum) HepII (PhHepII) efficiently cleaves the glucosamine-uronic acid linkages in heparin and heparan sulfate to produce unsaturated oligosaccharides.7) The crystal structure of PhHepII has been determined.8) 9) PhHepII forms a homodimer, and each subunit is composed of an N-terminal, a central, and a C-terminal domain (Fig. 1). The N-terminal domain is α-helical, whereas the central and C-terminal domains are primarily composed of β-strands. Based on the structure of the PhHepII-disaccharide complex, a deep cleft formed by the N-terminal and central domains has been identified as the catalytic cleft.8)
Fig 1.
Structure of PhHepII and sequence alignment with other PL21 proteins.
(A) Crystal structure of PhHepII. A monomer of PhHepII is shown. N-terminal, central, and C-terminal domains are indicated by different gray levels. The image was generated using PDB ID 3E7J, and the program PyMol (http://www.pymol.org/). (B) Sequence alignment of PL21 lyases, including PhHepII. Alignment was performed using the Clustal Omega server (http://www.ebi.ac.uk/Tools/msa/clustalo/). The loop-A sequence (residues 84-89) in PhHepII is underlined.
There is a long loop, designated here loop-A, consisting of amino acids 84-89 (Trp-Lys-Pro-Ala-Asp-Ile) in the N-terminal domain of PhHepII at the entrance of the catalytic cleft. In some enzymes, shortening of the surface loop has been reported to enhance enzymatic activity and/or stability.10) 11) Loop-A is located relatively far (~20 Å) from the catalytic cleft and does not appear to interact with the substrate (Fig. 1A). The modification of residues with high B values increases thermostability in some proteins.12) 13) In the crystal structure of the PhHepII (PDB ID, 2FUQ)8), the average B value of all of the amino acid residues is 29.4 Å2, whereas that of the amino acid residues within loop-A is 40.3 Å2, which is the highest B values in PhHepII. Also, conserved amino acid residues generally play a critical role in the activity.14) According to the CAZy database, 10 genes have been classified as PL21 lyases, and the sequences were aligned using the Clustal Omega server15) (http://www.ebi.ac.uk/Tools/msa/clustalo/) (Fig. 1B). The sequence alignment of the PL21 lyases shows that only PhHepII possesses the loop-A WKPADI sequence. Therefore, we predicted that shortening loop-A would enhance PhHepII thermostability without loss of the activity. In this study, two, three, or four residues were deleted from loop-A to create the mutants Δ86-87, Δ85-87, and 84-87 and determine whether shortening loop-A increases the thermostability of PhHepII.
MATERIALS AND METHODS
Plasmid construction.
P. heparinus NBRC 12017 was obtained from the NITE Biological Resource Center (Kisarazu, Japan). Escherichia coli strain JM109 was used for DNA manipulations. Wild-type (WT) HepII was cloned into an expression vector as described previously.8) Briefly, the PhHepII gene was amplified by PCR, and the PCR product was cloned into pET28a (Novagen®; Merck KGaA, Darmstadt, Germany). Site-directed mutagenesis of the resulting plasmid was carried out using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies, Inc., Santa Clara, USA). Primers for the construction of the deletion mutants were as follows: Δ86-87, 5′-ATG CAG GAA GAC TGG AAG GAT ATC CCT GAA GTT AAA GAC-3′; Δ85-87, 5′-ATG CAG GAA GAC TGG GAT ATC CCT GAA GTT AAA GAC-3′; and Δ84-87, 5′-C AAG ATG CAG GAA GAC GAT ATC CCT GAA GTT AAA GAC TTT-3′. Primers complementary to these sequences were also used. All constructs were verified by DNA sequencing.
Protein expression and purification.
WT and deletion mutant PhHepII expression constructs were transformed into E. coli BL21(DE3), and transformants were grown at 37 °C in 200 mL Luria-Bertani (LB) medium containing kanamycin (20 μg/mL) to A600 = 0.6 to 0.8. Cells were then induced with 0.5 mM isopropyl β-D-thiogalactoside and further cultivated at 30 °C for 18 h. Cells were harvested by centrifugation at 5,000 × G for 5 min, resuspended in 8 mL of 50 mM Tris-HCl (pH 7.5), and lysed by sonication. Lysed cells were centrifuged at 12,000 × G for 20 min, and the supernatant was applied onto a 5-mL column (diameter of 2.5 cm) containing nickel-nitrilotriacetic acid (Ni-NTA) agarose (Qiagen GmbH, Hilden, Germany). The column was equilibrated with 50 mM Tris-HCl and 0.5 M sodium chloride (buffer A), and the enzyme was eluted with 30 mL buffer A containing 50 mM imidazole (Fig. 2). The eluted fractions were collected and the original buffer was replaced with 50 mM sodium phosphate buffer (pH 7.0) using an Amicon Ultracell-30K centrifugal filter unit (Merck Millipore, Darmstadt, Germany).
Fig 2.
Enzymatic activity and thermostability of PhHepII.
(A) Thermostability of WT PhHepII. The enzyme was incubated under the indicated conditions, and the remaining activities were assayed at 25 °C for 10 min. The activity of unheated enzyme was calculated as 100 %. Bars represent the mean ∓ standard deviation. (B, C) Time course of product formation by unheated (B) and heat-treated (C) enzymes (25 μg/mL). Black circle, WT PhHepII; white square, Δ86-87 PhHepII; black triangle, Δ85-87 PhHepII; white circle, Δ84-87 PhHepII.
Enzymatic activity.
The substrate solution consisted of 70 μL heparin (10 mg/mL; Wako Pure Chemical Industries, Osaka, Japan) from pig intestinal mucosa and 560 μL buffer (0.01 % bovine serum albumin and 50 mM sodium phosphate, pH 7.0). Seventy microliters of enzyme (0.25 mg/mL in 50 mM sodium phosphate, pH 7.0; final concentration, 25 μg/mL) was added to the substrate solution to start the reaction, and the reaction was incubated at 25 °C. Aliquots (100 μL) were taken at 10 min or 5-min intervals and mixed with 1 mL of 60 mM HCl to stop the reaction. Absorbances at 232 nm were then measured. Each measurement was performed at least three times. Activity was calculated using a molar extinction coefficient of 3,800 M-1 cm-1 for unsaturated oligosaccharides.16) One unit (U) of activity was defined as the amount of enzyme that liberated 1 μmol unsaturated oligosaccharide per minute. Protein concentrations were determined by measuring the absorbance at 280 nm, and the molar extinction coefficient (1 mg/mL solution of WT, Δ86-87, and Δ85-87, = 1.60; 1 mg/mL solution of Δ84-87 = 1.54) was calculated using the Expasy ProtParam server (http://web.expasy.org/protparam/).
Circular dichroism (CD) spectroscopy.
CD spectra were obtained for WT and mutant enzymes (0.1 mg/mL) using a 0.1-cm cell in a JASCO J720WI spectrometer (JASCO Corporation, Tokyo, Japan) at 20 °C. Five spectra from 200-250 nm were taken at a scan speed of 50 nm/min with a bandwidth of 1 nm and averaged for each sample; buffer spectra were subtracted.
RESULTS
Purification of WT and mutant PhHepII.
WT, Δ86-87, Δ85-87, and Δ84-87 PhHepII were purified to homogeneity (Fig. S1; See J. Appl. Glycosci. Web site). In the purification of Δ86-87, Δ85-87, and Δ84-87, a small amount of PhHepII proteins was contained in the flow-through fractions (lanes 3 in Fig. S1; See J. Appl. Glycosci. Web site), but all the fractions eluted with buffer A containing 50 mM imidazole were observed as a single band on SDS-PAGE (lanes 4 in Fig. S1; See J. Appl. Glycosci. Web site). The eluted fractions were collected and used as the purified PhHepII.
Enzymatic activities and CD spectra of WT and mutant PhHepII.
We first investigated the thermostability of WT PhHepII under the condition used in this work. The enzyme (0.25 mg/mL) was incubated at various temperatures for 5 min or 30 min and the remaining activities were assayed at 25 °C for 10 min (Fig. 2A). About a half of the activity was remained when incubated at 37 °C for 30 min, but the activity was markedly decreased above 45 °C, and the remaining activity at 45 °C for 5 min was 6 %. A similar observation has been reported for the thermostability of Bacteroides stercoris HJ-15 HepII (58 % identity), which lose its activity rapidly above 40 °C.5)
The enzymatic activities of WT, Δ86-87, Δ85-87, and Δ84-87 PhHepII were determined by measuring product formation over time (Fig. 2B). When analyzed graphically, product formation was not linear but fit a square regression, probably because the substrate concentration decreased as the enzymatic reaction proceeded, leading to the deceleration of substrate degradation. Specific activities were calculated from three separate experiments (Table 1), and the specific activity of Δ86-87 PhHepII (3.93 ∓ 0.25 U/mg) was lower than that of WT (5.22 ∓ 0.26 U/mg). The activity of Δ85-87 was almost lost, and no enzymatic activity was detected for Δ84-87.
Table 1.
Specific activities of wild-type and deletion mutants of PhHepII.
| Enzyme | No treatment (U/mg) | After incubation at 45 °C for 5 min (U/mg) |
| WT | 5.22±0.26 | 0.318±0.044 |
| Δ86-87 | 3.93±0.25 | 0.415±0.034 |
| Δ85-87 | 0.130±0.035 | NDa |
| Δ84-87 | NDa | NDa |
aND, not detected.
To determine the thermostabilities of WT and mutant PhHepII enzymes, the enzymes were incubated at 45 °C for 5 min, and their specific and residual enzymatic activities were measured (Fig. 2C). Although the activities were low, the plots were well fit to the regression curves, indicating that the activities were accurately measured. The specific activity of heat-treated Δ86-87 PhHepII (0.415 ∓ 0.034 U/mg) was slightly higher than that of WT (0.318 ∓ 0.044 U/mg) (Table 1). The residual enzymatic activities of WT and Δ86-87 PhHepII were 6.1 and 10.6 %, respectively.
Far-UV CD spectra of WT, Δ86-87, and Δ85-87 PhHepII from 200-250 nm were analyzed to determine whether these mutations affected the folding of PhHepII (Fig. 3). WT and mutant CD spectra were superimposable.
Fig 3.
CD spectra of PhHepII from 200-250 nm.
The enzymes at a concentration of 0.1 mg/mL were analyzed. Solid black line, WT PhHepII; solid gray line, Δ86-87 PhHepII; dotted line, Δ85-87 PhHepII.
DISCUSSION
In this study, we hypothesized that shortening of loop-A would enhance the thermostability of PhHepII. When the enzymatic activities of unheated WT and Δ86-87 PhHepII were set to 100 %, heating at 45 °C for 5 min reduced the activities of WT and Δ86-87 PhHepII to 6.1 and 10.6 %, respectively (Fig. 3, Table 1). This result demonstrates that the thermostability of Δ86-87 PhHepII is slightly higher than that of WT. However, the specific activity of Δ86–87 PhHepII (3.93 U/mg) was 1.3-fold lower than that of WT (5.22 U/mg) and Δ85-87 PhHepII had very weak enzymatic activity (0.130 U/mg) (Table 1) indicating that loop-A is critical for PhHepII activity. The CD spectra of WT, Δ86-87, and Δ85-87 PhHepII were nearly identical indicating that deletion of residues 85-87 did not affect the folding of PhHepII (Fig. 3). While many rational approaches to thermostabilize proteins have been reported to be successful, this study shows that the molecular basis for the increased thermostability is extraordinarily subtle as suggested previously.13) 17) The sequence homology of PL21 proteins around loop-A was low (Fig. 1B), suggesting that the flexibility of the loop, rather than a single residue such as Lys85, is likely to be important for PhHepII activity.
It has been reported that one or two lid loops are present at the entrance of the catalytic cleft in PL5,18) PL7,19) and PL1820 enzymes. The PL5 alginate lyase A1-III from Sphingomonus sp. is composed of (α/α)6 barrel, and a lid loop, comprising residues 64-85, extends from the (α/α)6 barrel fold. Crystallography of a PL5 alginate lyase revealed a large conformational change in the lid loop during catalysis, and the maximum movement reaches 13.4 Å. Along with this loop motion, residues located in the loop, Arg67, Tyr68, and Tyr80, interact with the substrate.18) PL7 and PL16 lyases are composed of β-jelly roll, and a combination of two lid loops has been predicted to oscillate based on a structural comparison19) and a molecular dynamic simulation.20) Crystallography results demonstrated that the B values of the amino acids in the lid loops of a PL18 alginate lyase were also high.20) It is unclear whether a similar conformational change occurs in loop-A in PhHepII, but it has been reported that large loop motions may not be observed by protein crystallography due to the influence of crystal packing.21) Although the overall structure of PhHepII differs from the PL5, PL7, and PL18 alginate lyase structures, the loop-A of PhHepII likely contributes to enzymatic activity in a manner similar to the PL5, PL7, and PL18 lid loops.
Supplementary Material
WT (A), Δ86-87 PhHepII (B), Δ85-87 PhHepII (C), and Δ84-87 PhHepII (D). Lanes: 1: molecular mass marker (labeled in kDa); 2: crude cell extract; 3: Ni-NTA column flow-through; 4: Ni-NTA column eluate. Arrows indicate PhHepII proteins.
REFERRENCES
- 1).Kjellén L. and Lindahl U.: Proteoglycans: structures and interactions. Annu. Rev. Biochem., 60, 443-475 (1991). [DOI] [PubMed] [Google Scholar]
- 2).Linhardt R.J., Galliher P.M., and Cooney C.L.: Polysaccharide lyases. Appl. Biochem. Biotechnol., 12, 135-176 (1986). [DOI] [PubMed] [Google Scholar]
- 3).Garron M.L. and Cygler M.: Structural and mechanistic classification of uronic acid-containing polysaccharide lyases. Glycobiology, 20, 1547-1573 (2010). [DOI] [PubMed] [Google Scholar]
- 4).Linhardt R.J., Turnbull J.E., Wang H.M., Loganathan D., and Gallagher J.T.: Examination of the substrate specificity of heparin and heparan sulfate lyases. Biochemistry, 29, 2611-2617 (1990). [DOI] [PubMed] [Google Scholar]
- 5).Hyun Y.J., Lee K.S., and Kim D.H.: Cloning, expression and characterization of acharan sulfate-degrading heparin lyase II from Bacteroides stercoris HJ-15. J. Appl. Microbiol., 108, 226-235 (2010). [DOI] [PubMed] [Google Scholar]
- 6).Lombard V., Golaconda Ramulu H., Drula E., Coutinho P.M., and Henrissat B.: The Carbohydrate-active enzymes database (CAZy) in 2013. Nucleic Acids Res., 42, D490-D495 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7).Nader H.B., Porcionatto M.A., Tersariol I.L., Pinhal M.A., Oliveira F.W., Moraes C.T., and Dietrich C.P.: Purification and substrate specificity of heparitinase I and heparitinase II from Flavobacterium heparinum. Analyses of the heparin and heparan sulfate degradation products by 13C NMR spectroscopy. J. Biol. Chem., 265, 16807-16813 (1990). [PubMed] [Google Scholar]
- 8).Shaya D., Tocilj A., Li Y., Myette J., Venkataraman G., Sasisekharan R., and Cygler M.: Crystal structure of heparinase II from Pedobacter heparinus and its complex with a disaccharide product. J. Biol. Chem., 281, 15525-15535 ( 2006). [DOI] [PubMed] [Google Scholar]
- 9).Shaya D., Zhao W., Garron M.L., Xiao Z., Cui Q., Zhang Z., Sulea T., Linhardt R.J., and Cygler M.: Catalytic mechanism of heparinase II investigated by site-directed mutagenesis and the crystal structure with its substrate. J. Biol. Chem., 285, 20051-20061 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10).Meinke A., Damude H.G., Tomme P., Kwan E., Kilburn D.G., Miller Jr R.C., Warren R.A., and Gilkes N.R.: Enhancement of the endo-β-1,4-glucanase activity of an exocellobiohydrolase by deletion of a surface loop. J. Biol. Chem., 270, 4383-4386 (1995). [DOI] [PubMed] [Google Scholar]
- 11).Thompson M.J. and Eisenberg D.: Transproteomic evidence of a loop-deletion mechanism for enhancing protein thermostability. J. Mol. Biol., 290, 595-604 (1999). [DOI] [PubMed] [Google Scholar]
- 12).Reetz M.T., Carballeira J.D., and Vogel A.: Iterative saturation mutagenesis on the basis of B factors as a strategy for increasing protein thermostability. Angew. Chem. Int. Ed. Engl., 45, 7745-7751 (2006). [DOI] [PubMed] [Google Scholar]
- 13).Ohta Y., Hatada Y., Hidaka Y., Shimane Y., Usui K., Ito T., Fujita K., Yokoi G., Mori M., Sato S., Miyazaki T., Nishikawa A., and Tonozuka T.: Enhancing thermostability and the structural characterization of Microbacterium saccharophilum K-1 β-fructofuranosidase. Appl. Microbiol. Biotechnol., 98, 6667-6677 (2014). [DOI] [PubMed] [Google Scholar]
- 14).Poole A.M. and Ranganathan R.: Knowledge-based potentials in protein design. Curr. Opin. Struct. Biol., 16, 508-513 (2006). [DOI] [PubMed] [Google Scholar]
- 15).McWilliam H., Li W., Uludag M., Squizzato S., Park Y.M., Buso N., Cowley A.P., and Lopez R.: Analysis Tool Web Services from the EMBL-EBI. Nucleic Acids Res., 41, W597-W600 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16).Lohse D.L. and Linhardt R.J.: Purification and characterization of heparin lyases from Flavobacterium heparinum. J. Biol. Chem., 267, 24347-24355 (1992). [PubMed] [Google Scholar]
- 17).Dumon C., Varvak A., Wall M.A., Flint J.E., Lewis R.J., Lakey J.H., Morland C., Luginbühl P., Healey S., Todaro T., DeSantis G., Sun M., Parra-Gessert L., Tan X., Weiner D.P., and Gilbert H.J.: Engineering hyperthermostability into a GH11 xylanase is mediated by subtle changes to protein structure. J. Biol. Chem., 283, 22557-22564 (2008). [DOI] [PubMed] [Google Scholar]
- 18).Mikami B., Ban M., Suzuki S., Yoon H.J., Miyake O., Yamasaki M., Ogura K., Maruyama Y., Hashimoto W., and Murata K.: Induced-fit motion of a lid loop involved in catalysis in alginate lyase A1-III. Acta Crystallogr. D Biol. Crystallogr., 68, 1207-1216 (2012). [DOI] [PubMed] [Google Scholar]
- 19).Yamasaki M., Ogura K., Hashimoto W., Mikami B., and Murata K.: A structural basis for depolymerization of alginate by polysaccharide lyase family-7. J. Mol. Biol., 352, 11-21 (2005). [DOI] [PubMed] [Google Scholar]
- 20).Dong S., Wei T.D., Chen X.L., Li C.Y., Wang P., Xie B.B., Qin Q.L., Zhang X.Y., Pang X.H., Zhou B.C., and Zhang Y.Z.: Molecular insight into the role of the N-terminal extension in the maturation, substrate recognition, and catalysis of a bacterial alginate lyase from polysaccharide lyase family 18. J. Biol. Chem., 289, 29558-29569 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21).Tamura M., Miyazaki T., Tanaka Y., Yoshida M., Nishikawa A., and Tonozuka T.: Comparison of the structural changes in two cellobiohydrolases, CcCel6A and CcCel6C, from Coprinopsis cinerea - a tweezer-like motion in the structure of CcCel6C. FEBS J., 279, 1871-1882 (2012). [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
WT (A), Δ86-87 PhHepII (B), Δ85-87 PhHepII (C), and Δ84-87 PhHepII (D). Lanes: 1: molecular mass marker (labeled in kDa); 2: crude cell extract; 3: Ni-NTA column flow-through; 4: Ni-NTA column eluate. Arrows indicate PhHepII proteins.



